FALBERG KATHRYN E — SEC Form 4 filings
SEC reporting owner CIK 1206977. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-12 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 405,858 shares, $27,818,813 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 150,000 shares @ $98.17 ($14,725,500) in Trade Desk, Inc., filed 2024-08-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Trade Desk, Inc. (TTD) | Director | 7 | — | 5 legs · 405,858 sh · $27,818,813 | 16 |
| Arcus Biosciences, Inc. (RCUS) | Director | 3 | — | — | 6 |
| Nuvation Bio Inc. (NUVB) | Director | 3 | — | — | 3 |
Form 4 filings — FALBERG KATHRYN E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 123,397 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Trade Desk, Inc. (TTD) | Disposition to issuer (D): 1,226 @ $0 · Disposition to issuer (D): 212 @ $59.17 · Disposition to issuer (D): 296 @ $59.17 · Disposition to issuer (D): 212 @ $59.17 | EDGAR |
| 2026-03-09 | 4 | Trade Desk, Inc. (TTD) | Sale (S): 102,828 @ $30.45 · Sale (S): 50,000 @ $30.48 | EDGAR |
| 2025-06-12 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Trade Desk, Inc. (TTD) | Grant/award (A): 4,901 @ $0 · Grant/award (A): 845 @ $59.17 · Grant/award (A): 1,183 @ $59.17 · Grant/award (A): 845 @ $59.17 | EDGAR |
| 2025-05-23 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 292,983 (derivative) @ $0 | EDGAR |
| 2025-04-17 | 4 | Trade Desk, Inc. (TTD) | Grant/award (A): 90 @ $63.73 | EDGAR |
| 2024-09-05 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 200,801 (derivative) @ $0 | EDGAR |
| 2024-08-15 | 4 | Trade Desk, Inc. (TTD) | Sale (S): 150,000 @ $98.17 | EDGAR |
| 2024-06-07 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 8,400 @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Trade Desk, Inc. (TTD) | Grant/award (A): 3,155 @ $0 · Grant/award (A): 573 @ $87.16 · Grant/award (A): 573 @ $87.16 | EDGAR |
| 2024-03-12 | 4 | Trade Desk, Inc. (TTD) | Conversion (C): 103,030 @ $1.80 · Sale (S): 102,935 @ $81.90 · Sale (S): 95 @ $82.36 · Option exercise (M): 103,030 (derivative) @ $0 · Option exercise (M): 103,030 (derivative) @ $0 · Conversion (C): 103,030 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1206977 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →